Research & Grants

In just the past decade, doctors have more tools to fight lung cancer than ever before in the history of lung cancer diagnosis, treatment and survival. Advances in imaging for diagnosis, discovery of tumor mutations, thanks to genomic testing, targeted therapies and immunotherapies (aka personalized medicine) are bringing lung cancer to an inflection point… yielding an increase in survival rates never before realized in lung cancer. These discoveries, combined with the “Moonshot” for cancer and LCFA’s experience and deep connections to the lung cancer research community, position LCFA, with your support, as the go-to organization for transformative research that will positively impact lung cancer survival.

No research question gets answered without a financial cost.
Dr. Steven Dubinett